Issue link: https://www.e-digitaleditions.com/i/1527415
This section provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. 30 OctOber 2024 Inhalation SPECIAL SECTION Outsourcing Services This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. Integrated solutions for pulmonary and nasal delivery With 30+ years' experience in pulmonary and nasal delivery, Catalent offers integrated solutions with clinical- to commercial-scale development and man- ufacturing capabilities for dry powder inhalers and vials for nebulization as well as unit-dose, bi-dose and multi-dose nasal products. In addition, Catal- ent provides comprehensive analytical, bioanalytical and clinical-supply services to support your mole- cule from development through product launch and beyond. With state-of-the-art facilities in Boston, MA, US and Morrisville, NC, US, Catalent can han- dle the most complex projects and help bring your inhaled therapy to market, faster. Catalent Inhalation US: +1 888 SOLUTION (765-8846) solutions@catalent.com www.catalent.com Best practices, new tests and technologies Partnering with Proveris Laboratories ensures use of industry best practices, the expertise to interpret results, and access to new technologies to acceler- ate orally inhaled and nasal drug product (OINDP) development. e Proveris by Design™ process, employed by Proveris Laboratories, creates the short- est path to submission for clients. By regularly inte- grating new tests and technologies such as spray velocity, evaporation fraction and human-realistic regional deposition, clients evaluate products accord- ing to the most current regulatory guidance docu- ments and adapt development needs for product success. Learn about these techniques and see pub- lished data on the Proveris website. Proveris Laboratories US: +1 508 460-8822 contactus@proveris.com www.proveris.com Particle engineering services Particle engineering is being used increasingly in drug development, particularly for complex dosage forms such as OINDPs, where deposition in the smaller air- ways is key to efficacy. Particle engineering can offer many advantages in terms of tailoring the particle size for targeted delivery, as well as offering a more con- trolled manufacturing process, which is also suitable for the formulation of biologics. Intertek is an expert in the spray drying of small and large molecules for respiratory products and has partnerships in place that support other particle engineering approaches, such as anti-solvent precipitation. Intertek Pharmaceutical Services UK: +44 1763 261648 bd.melbourn@intertek.com www.intertek.com